OptimizeRx (OPRX) Depreciation & Amortization (CF) (2010 - 2026)

OptimizeRx has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 2.74% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (down 1.38% YoY) and the FY2025 annual result came in at $4.3 million, changed 0.05% from the prior year.
• Depreciation & Amortization (CF) declined to $1.1 million in Q1 2026 per OPRX's latest filing, from $1.1 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.1 million in Q3 2024 and troughed at $456545.0 in Q4 2022.
• A 5-year average of $832001.7 and a median of $1.1 million in 2026 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) slipped 19.57% in 2023, then surged 134.48% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $456545.0 in 2022, then jumped by 120.57% to $1.0 million in 2023, then grew by 8.64% to $1.1 million in 2024, then retreated by 1.46% to $1.1 million in 2025, then declined by 1.3% to $1.1 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.1 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.